XML 131 R114.htm IDEA: XBRL DOCUMENT v3.8.0.1
Net Sales by GBU (Detail) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Revenue from External Customer [Line Items]                      
Net sales $ 2,774 $ 2,707 $ 2,605 $ 2,475 $ 2,645 $ 2,558 $ 2,585 $ 2,375 $ 10,561 $ 10,163 $ 9,968
Renal                      
Revenue from External Customer [Line Items]                      
Net sales [1]                 3,480 3,421 3,401
Acute Therapies                      
Revenue from External Customer [Line Items]                      
Net sales [2]                 456 429 385
Medication Delivery                      
Revenue from External Customer [Line Items]                      
Net sales [3]                 2,698 2,596 2,375
Pharmaceuticals                      
Revenue from External Customer [Line Items]                      
Net sales [4]                 1,883 1,722 1,801
Nutrition                      
Revenue from External Customer [Line Items]                      
Net sales [5]                 882 858 857
Advanced Surgery                      
Revenue from External Customer [Line Items]                      
Net sales [6]                 707 690 693
Other                      
Revenue from External Customer [Line Items]                      
Net sales [7]                 $ 455 $ 447 $ 456
[1] Renal Care includes sales of the company’s peritoneal dialysis (PD) and hemodialysis (HD) and additional dialysis therapies and services.
[2] Acute Therapies includes sales of the company’s continuous renal replacement therapies (CRRT) and other organ support therapies focused in the ICU.
[3] Medication Delivery includes sales of the company’s IV therapies, infusion pumps, administration sets and drug reconstitution devices.
[4] Pharmaceuticals includes sales of the company’s premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services.
[5] Nutrition includes sales of the company’s parenteral nutrition (PN) therapies.
[6] Advanced Surgery includes sales of the company’s biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention.
[7] Other includes sales primarily from the company’s pharmaceutical partnering business.